Literature DB >> 8656989

Superparamagnetic iron oxide (SPIO) as an oral contrast agent in gastrointestinal (GI) magnetic resonance imaging (MRI): comparison with state-of-the-art computed tomography (CT).

W K Johnson1, C Stoupis, G M Torres, E B Rosenberg, P R Ros.   

Abstract

This study was conducted to compare the sensitivity and specificity of abdominal magnetic resonance imaging using oral superparamagnetic iron oxide with oral contrast-enhanced computed tomography in the detection of GI pathology. Overall sensitivity was calculated to be 83% for OECT compared to 67% by SPIO MRI. Specificity for OECT was 68% compared to 89% for SPIO MRI. The results from imaging with superparamagnetic iron oxide and imaging with oral contrast-enhanced computed tomography were in agreement in 14 subjects who had normal gastrointestinal tracts. In the remaining 16 patients, eight pathologic entities were detected by both modalities whereas 15 abnormalities were seen by only one modality. Superparamagnetic iron oxide magnetic resonance imaging was helpful in discriminating normal bowel from solid lesions and in detecting subtle gastrointestinal tract mass effect. In 30 consecutively studied patients suspected of having GI pathology, OECT was more sensitive than SPIO MRI in detecting abdominal pathology. Conversely, SPIO MRI was more specific than OECT.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8656989     DOI: 10.1016/0730-725x(95)02044-t

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  9 in total

Review 1.  Updating magnetic resonance imaging of small bowel: imaging protocols and clinical indications.

Authors:  Jiong Zhu; Jian-Rong Xu; Hong-Xia Gong; Yan Zhou
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 2.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

3.  3D bioprinting of tissues and organs.

Authors:  Sean V Murphy; Anthony Atala
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

4.  Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications.

Authors:  Mrinmoy De; Stanley S Chou; Hrushikesh M Joshi; Vinayak P Dravid
Journal:  Adv Drug Deliv Rev       Date:  2011-08-06       Impact factor: 15.470

5.  Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents.

Authors:  Sang Young Jeong; Hyo Jeong Kim; Byung-Kook Kwak; Ha-Young Lee; Hasoo Seong; Byung Cheol Shin; Soon Hong Yuk; Sung-Joo Hwang; Sun Hang Cho
Journal:  Nanoscale Res Lett       Date:  2010-09-02       Impact factor: 4.703

6.  Magnetic resonance imaging for the in vivo evaluation of gastric-retentive tablets.

Authors:  Andreas Steingoetter; Dominik Weishaupt; Patrick Kunz; Karsten Mäder; Hans Lengsfeld; Miriam Thumshirn; Peter Boesiger; Michael Fried; Werner Schwizer
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

7.  Tracking injectable microspheres in dynamic tissues with encapsulated superparamagnetic iron oxide nanoparticles.

Authors:  Travelle Franklin-Ford; Nehal Shah; Ellen Leiferman; Connie S Chamberlain; Amish Raval; Ray Vanderby; William L Murphy
Journal:  Macromol Biosci       Date:  2012-11-01       Impact factor: 4.979

8.  Use of trimetasphere metallofullerene MRI contrast agent for the non-invasive longitudinal tracking of stem cells in the lung.

Authors:  Sean V Murphy; Austin Hale; Tanya Reid; John Olson; Amritha Kidiyoor; Josh Tan; Zhiguo Zhou; John Jackson; Anthony Atala
Journal:  Methods       Date:  2015-11-10       Impact factor: 3.608

9.  Biomedical properties and preparation of iron oxide-dextran nanostructures by MAPLE technique.

Authors:  Carmen Steluta Ciobanu; Simona Liliana Iconaru; Eniko Gyorgy; Mihaela Radu; Marieta Costache; Anca Dinischiotu; Philippe Le Coustumer; Khalid Lafdi; Daniela Predoi
Journal:  Chem Cent J       Date:  2012-03-13       Impact factor: 4.215

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.